Certainly. I am actually very proud and excited that COVAX exists in the first place, because this is the first time there's been a global mechanism to confront a global health crisis of this nature. It's actually the largest multilateral initiative since the Paris climate accord and it really is about the world coming together to try to provide equitable access to vaccines around the world. Canada is one of the largest contributors to COVAX. We provided $325 million. We were the second-largest contributor until the U.S. joined, and of course we welcome the U.S. contribution of $2 billion. That's a good thing, because it's going to help us procure even more doses for lower-income countries right around the world.
But Canada was instrumental in getting COVAX set up. We worked with Gavi and the WHO back in June already, and actually Josh Tabah, who's on the line with us, and his team were instrumental in getting COVAX set up. Canada provided the first $25 million from what was left over from our Gavi pneumococcal vaccine contribution, to establish COVAX. We were one of the first G7 countries to say that we were going to make a commitment to COVAX and to say that this was a mechanism worth investing in, and because of that, I am also the COVAX AMC—advance market commitment—co-chair, working with Indonesia and Ethiopia, to ensure that we have a successful rollout for low- and middle-income countries around the world.
I can turn it over to Josh, if you're interested, for a comparison with the donations from other G20 countries.